Erythrocyte-mediated delivery of bioorthogonal nanozymes for selective targeting of bacterial infections.
Ontology highlight
ABSTRACT: Bioorthogonal transformation of imaging and therapeutic substrates using transition metal catalysts (TMCs) provides a toolkit with diverse applications in biomedicine. Controlled localization of bioorthogonal catalysis is key for enhancing their therapeutic efficacy by minimizing off-target effects. Red blood cells (RBCs) are highly biocompatible and are susceptible to hemolysis by bacterial toxins, providing them with intrinsic targeting to bacterial infections. A hitchhiking strategy using RBCs is reported, that activates bioorthogonal catalysis at infection sites. A library of nanoparticles embedded with TMCs (nanozymes) featuring diverse functional groups with different binding ability to RBCs is generated. These engineered nanozymes bind to RBCs and subsequently release upon hemolysis
SUBMITTER: Gupta A
PROVIDER: S-EPMC8629964 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA